We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DMAC icon
13126
CALL
DiaMedica Therapeutics
DMAC
$360M
$58K ﹤0.01%
+13,000
New +$107K
GAU
13127
CALL
Galiano Gold
GAU
$547M
$58K ﹤0.01%
53,200
-23,800
-31% -$28.9K
PRPO icon
13128
CALL
Precipio
PRPO
$42M
$58K ﹤0.01%
+800
New +$52.5K
TRIB
13129
Trinity Biotech
TRIB
$7.88M
$58K ﹤0.01%
133
+36
+37% +$18K
HIL
13130
PUT
DELISTED
Hill International, Inc. Common Stock
HIL
$58K ﹤0.01%
23,400
+9,900
+73% +$26.4K
TYME
13131
PUT
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$58K ﹤0.01%
46,200
-11,400
-20% -$16.4K
SBBP
13132
DELISTED
Strongbridge Biopharma plc.
SBBP
$58K ﹤0.01%
19,499
-1,866
-9% -$4.93K
NBRV
13133
CALL
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$58K ﹤0.01%
1,732
+760
+78% +$28.3K
REFR icon
13134
CALL
Research Frontiers
REFR
$15.3M
$57K ﹤0.01%
24,100
+300
+1% +$747
TONX
13135
TON Strategy Co
TONX
$148M
$57K ﹤0.01%
+3
New +$29.1K
ZVO
13136
DELISTED
Zovio Inc. Common Stock
ZVO
$57K ﹤0.01%
22,183
-18,862
-46% -$57.7K
ALJJ
13137
DELISTED
ALJ Regional Holdings Inc
ALJJ
$57K ﹤0.01%
31,213
+16,524
+112% +$24.6K
CALA
13138
DELISTED
Calithera Biosciences, Inc
CALA
$57K ﹤0.01%
+1,371
New +$60.2K
NAVB
13139
PUT
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$57K ﹤0.01%
31,400
+8,000
+34% +$14.1K
ANY icon
13140
Sphere 3D
ANY
$18.1M
$56K ﹤0.01%
+305
New +$43.4K
KEEL
13141
Keel Infrastructure Corp
KEEL
$2.17B
$56K ﹤0.01%
+14,290
New +$58.5K
HYMC icon
13142
Hycroft Mining Holding Corp
HYMC
$2.52B
$56K ﹤0.01%
1,821
-3,716
-67% -$137K
MMLP icon
13143
PUT
Martin Midstream Partners
MMLP
$93.9M
$56K ﹤0.01%
18,500
+8,400
+83% +$22K
SLNO
13144
CALL
DELISTED
Soleno Therapeutics
SLNO
$56K ﹤0.01%
3,273
+1,733
+113% +$29.3K
SVRA icon
13145
PUT
Savara
SVRA
$1.11B
$56K ﹤0.01%
33,000
-64,600
-66% -$116K
TOUR
13146
PUT
Tuniu
TOUR
$53.2M
$56K ﹤0.01%
2,370
+130
+6% +$3.55K
GNCA
13147
PUT
DELISTED
Genocea Biosciences, Inc.
GNCA
$56K ﹤0.01%
24,100
+8,200
+52% +$19.8K
IMH
13148
DELISTED
Impac Mortgage Holdings Inc.
IMH
$56K ﹤0.01%
+26,254
New +$53.9K
CCO icon
13149
PUT
Clear Channel Outdoor Holdings
CCO
$1.19B
$55K ﹤0.01%
20,900
+8,500
+69% +$20.4K
DBVT
13150
PUT
DBV Technologies
DBVT
$881M
$55K ﹤0.01%
+1,000
New +$59.8K

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.